Search Result "ofatumumab"
Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for the Treatment of Chronic Lymphocytic Leukemia
Journal: Current Drug Therapy
Volume: 7 Issue: 4 Year: 2012 Page: 281-289
Author(s): Ravindra R. Chuda,Prakash Vishnu,David Aboulafia
Ofatumumab and Early Immunological Cells Subset Characterization inNaïve Relapsing Multiple Sclerosis Patients: A Real-World Study
Journal: Current Neuropharmacology
Volume: 21 Issue: 12 Year: 2023 Page: 2563-2566
Author(s):
Therapeutic Approach to Patients with Chronic Lymphocytic Leukemia and Significant Comorbid Conditions
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 8 Year: 2016 Page: 710-720
Author(s): Lukas Smolej
Refractory Chronic Lymphocytic Leukemia: A Therapeutic Challenge
Journal: Current Cancer Drug Targets
Volume: 16 Issue: 8 Year: 2016 Page: 701-709
Author(s): Lukas Smolej
Characterization of Protein Higher Order Structure Using Vibrational Circular Dichroism Spectroscopy
Journal: Current Pharmaceutical Biotechnology
Volume: 14 Issue: 2 Year: 2013 Page: 199-208
Author(s): Radhika P. Nagarkar,Brian M. Murphy,Xiaotong Yu,Mark Cornell Manning,Wasfi A. Al-Azzam
Therapy of Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 23 Year: 2012 Page: 3399-3405
Author(s): Lukas Smolej
Monoclonal Antibodies in Lymphoma
Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 2 Year: 2016
Author(s): Esmeralda Chi-yuan Teo,Colin Phipps
Doi: 10.2174/9781681081816116020007
Immune Therapy of Multiple Sclerosis - Future Strategies
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 29 Year: 2012 Page: 4489-4497
Author(s): Sven G. Meuth,Kerstin Gobel,Heinz Wiendl
Current Understanding and Unknown Aspects of the Treatment of Granulomatosis with Polyangiitis (Wegener's Granulomatosis): Opportunities for Future Studies
Journal: Current Rheumatology Reviews
Volume: 16 Issue: 4 Year: 2020 Page: 257-266
Author(s): Samira Alesaeidi,Mohammad Darvishi,Sasan Dabiri,Mojtaba GhasemiAdl,Arash Jafarieh,Soheil Tavakolpour
Removal of the Tag from His-tagged ILYd4, a Human CD59 Inhibitor, Significantly Improves its Physical Properties and its Activity
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 27 Year: 2012 Page: 4187-4196
Author(s): Lin Wu,Sanbao Su,Fengming Liu,Tao Xu,Xiaoxiao Wang,Yan Huang,Xinlu Sun,Xiaowen Ge,Ting Chen,Huixia Liu,Chun Wang,Michael Chorev,Ting Xu,Xuebin Qin